← Return to Our journey on ALTA3263 clinical trial (tumors with KRAS mutations)

Discussion
howleegirl avatar

Our journey on ALTA3263 clinical trial (tumors with KRAS mutations)

Pancreatic Cancer | Last Active: 6 days ago | Replies (30)
Comment receiving replies
Profile picture for howleegirl @howleegirl

Is anyone on this trial? What kind of side effects are you having? How long are they lasting?

Jump to this post

Replies to "Is anyone on this trial? What kind of side effects are you having? How long are..."
mcharlesfrancis | @mcharlesfrancis | Jun 13 7:57am

At this point, ALTA3263 is still in Phase 1 testing, so there is very limited human side-effect data publicly available. The trial's primary purpose is to determine safety, tolerability, and dosing.

Based on experience with other KRAS inhibitors, oncologists will likely be watching closely for:

Diarrhea
Nausea
Fatigue
Rash or skin changes
Elevated liver enzymes
Decreased appetite
Blood count abnormalities

VIEW AND REPLY